Halozyme Therapeutic (NQ: HALO )

43.03 USD +1.26 (+3.02%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2021 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
May 02, 2019
Form DEF 14A
Source: SEC/Edgar
March 21, 2019
Form DEFA14A
Source: SEC/Edgar
March 21, 2019
Form PRE 14A
Source: SEC/Edgar
February 28, 2019
Form 8-K
Source: SEC/Edgar
February 20, 2019
Form SC 13G/A
Source: SEC/Edgar
February 12, 2019
Form SC 13G/A
Source: SEC/Edgar
February 10, 2019
Form SC 13G/A
Source: SEC/Edgar
February 05, 2019
Form SC 13G/A
Source: SEC/Edgar
February 03, 2019
Form 8-K
Source: SEC/Edgar
January 08, 2019
Form CT ORDER
Source: SEC/Edgar
December 19, 2018
Form 8-K
Source: SEC/Edgar
December 12, 2018
Form 8-K
Source: SEC/Edgar
November 25, 2018
Form 8-K
Source: SEC/Edgar
November 05, 2018
Form 8-K
Source: SEC/Edgar
September 09, 2018
Form 8-K
Source: SEC/Edgar
September 04, 2018
Form SC 13D/A
Source: SEC/Edgar
August 27, 2018
Form SC 13D/A
Source: SEC/Edgar
August 15, 2018
Form 8-K
Source: SEC/Edgar
August 06, 2018
Form 8-K
Source: SEC/Edgar
May 09, 2018
Form S-8
Source: SEC/Edgar
May 09, 2018
Form 8-K
Source: SEC/Edgar
May 01, 2018
Form DEFA14A
Source: SEC/Edgar
April 05, 2018
Form 8-K
Source: SEC/Edgar
April 05, 2018
Form DEFA14A
Source: SEC/Edgar
April 02, 2018
Form 8-K
Source: SEC/Edgar
March 21, 2018
Form DEF 14A
Source: SEC/Edgar
March 21, 2018
Form DEFA14A
Source: SEC/Edgar
March 21, 2018
Form 8-K
Source: SEC/Edgar
February 19, 2018
Form SC 13G/A
Source: SEC/Edgar
February 13, 2018
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.